TwinStrand Biosciences

TwinStrand Biosciences is an American gene sequencing technology developer. The company's proprietary Duplex Sequencing technology can be used for early cancer monitoring, genetic toxicology analysis, and drug development. It also provides doctors with critical information needed for key clinical decision-making. Duplex Sequencing is an upgrade to existing DNA sequencing platforms based on biochemistry and software technologies. By identifying ultra-low frequency DNA mutations with 10,000 times higher resolution than conventional methods, it helps make clinically significant decisions.